🎉 📣 [Warm Welcome for Arvinas to the CDDF Multi-Stakeholder Community]
The Cancer Drug Development Forum (CDDF) is excited to introduce our new Industry member, Arvinas, who will make collaborative efforts with the CDDF to improve cancer drug development.
Arvinas is dedicated to advancing PROTAC® protein degraders in oncology, including against targets that have traditionally been deemed “undruggable.”
We are thrilled to have our new member aboard who will bring invaluable insight and expertise that help the oncology community move forward towards the mission to enhance cancer treatment.